Medical Data Vision Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Hiroyuki Iwasaki

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	10.1yrs
Eigentum des Geschäftsführers	2.1%
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	8.6yrs

Jüngste Management Updates

Recent updates

Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Jun 25

Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching

Jun 13

Geschäftsführer

Hiroyuki Iwasaki (64 yo)

10.1yrs

Amtszeit

Mr. Hiroyuki Iwasaki has been the President and Representative Director of Medical Data Vision Co., Ltd. since September 2014 and serves as its Chairman. Mr. Hiroyuki Iwasaki joined Shin Nihonkokan Co., Lt...

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Hiroyuki Iwasaki	Chairman & President	10.1yrs	keine Daten	2.1% ¥ 434.7m
Syuuji Asami	Senior MD	21.2yrs	keine Daten	0.23% ¥ 48.5m
Takuji Yanagisawa	GM of Business Planning Division	16.3yrs	keine Daten	0.22% ¥ 44.6m
Masaki Nakamura	GM of the Alliance Promotion Office & Director	6.6yrs	keine Daten	0.0034% ¥ 711.4k
Soichi Katsuki	Independent Outside Director	8.6yrs	keine Daten	0.042% ¥ 8.7m
Kiyohito Hamada	Independent Outside Audit & Supervisory Board Member	10.6yrs	keine Daten	keine Daten
Osamu Nakagawa	Audit & Supervisory Board Member	11.6yrs	keine Daten	keine Daten
Takao Nakamura	Independent Outside Director	5.6yrs	keine Daten	keine Daten
Yasunori Matsumoto	Independent Outside Audit & Supervisory Board Member	6.6yrs	keine Daten	keine Daten
Masaaki Takaki	Independent Outside Full-Time Audit & Supervisory Board Member	2.6yrs	keine Daten	keine Daten
Kiyomi Nojiro	Independent Outside Director	less than a year	keine Daten	keine Daten

8.6yrs

Durchschnittliche Betriebszugehörigkeit

61yo

Durchschnittliches Alter

Erfahrener Vorstand: 3902Die Vorstandsmitglieder gelten als erfahren (9.8 Jahre durchschnittliche Amtszeit).

Medical Data Vision Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Jüngste Management Updates

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 27, 2024

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 28, 2023

Less than half of directors are independent

Less than half of directors are independent

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 29, 2022

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 23, 2021

Recent updates

Medical Data Vision (TSE:3902) Will Pay A Dividend Of ¥6.50

Medical Data Vision Co., Ltd. (TSE:3902) announces an Equity Buyback for 2,000,000 shares, representing 5.24% for ¥1,000 million.

Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Medical Data Vision Co., Ltd. to Report Q3, 2024 Results on Nov 11, 2024

New minor risk - Profit margin trend

Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Dividend of JP¥6.50 announced

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Medical Data Vision Co., Ltd. to Report Q2, 2024 Results on Aug 08, 2024

Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching

New minor risk - Share price stability

First quarter 2024 earnings released: JP¥0.39 loss per share (vs JP¥7.20 profit in 1Q 2023)

Now 21% overvalued

Now 22% overvalued

Medical Data Vision Co., Ltd. to Report Q1, 2024 Results on May 13, 2024

Full year 2023 earnings released: EPS: JP¥25.63 (vs JP¥22.75 in FY 2022)

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 27, 2024

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Medical Data Vision Co., Ltd. to Report Fiscal Year 2023 Results on Feb 13, 2024

Upcoming dividend of JP¥6.50 per share at 1.1% yield

Now 23% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: JP¥5.60 (vs JP¥6.65 in 3Q 2022)

Now 21% undervalued after recent price drop

Medical Data Vision Co., Ltd. to Report Q3, 2023 Results on Nov 13, 2023

Now 23% undervalued after recent price drop

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: JP¥4.45 (vs JP¥5.47 in 2Q 2022)

Price target decreased by 14% to JP¥815

Medical Data Vision Co., Ltd. to Report Q2, 2023 Results on Aug 10, 2023

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

First quarter 2023 earnings released: EPS: JP¥7.20 (vs JP¥8.16 in 1Q 2022)

Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023

Full year 2022 earnings: EPS and revenues miss analyst expectations

Full year 2022 earnings: EPS and revenues miss analyst expectations

Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2023

Price target decreased by 15% to JP¥1,010

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 28, 2023

Medical Data Vision Co., Ltd. to Report Fiscal Year 2022 Results on Feb 13, 2023

Upcoming dividend of JP¥6.00 per share

Less than half of directors are independent

Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2022

Medical Data Vision Co., Ltd. to Report Q3, 2022 Results on Nov 14, 2022

Medical Data Vision Provides Dividend Guidance for the Fiscal Year Ending December 31, 2022

Second quarter 2022 earnings released: EPS: JP¥5.47 (vs JP¥4.47 in 2Q 2021)

Medical Data Vision Co., Ltd. to Report Q2, 2022 Results on Aug 08, 2022

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022

Price target decreased to JP¥1,220

Less than half of directors are independent

Medical Data Vision Co., Ltd. to Report Q1, 2022 Results on May 12, 2022

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 29, 2022

Medical Data Vision Co., Ltd. (TSE:3902) announces an Equity Buyback for 800,000 shares, representing 2.05% for ¥1,000 million.

Upcoming dividend of JP¥5.00 per share

Price target decreased to JP¥2,275

Third quarter 2021 earnings released: EPS JP¥5.49 (vs JP¥5.28 in 3Q 2020)

Medical Data Vision Co., Ltd. (TSE:3902) announces an Equity Buyback for 200,000 shares, representing 0.51% for ¥345 million.

Second quarter 2021 earnings released: EPS JP¥4.47 (vs JP¥4.26 in 2Q 2020)

First quarter 2021 earnings released: EPS JP¥7.84 (vs JP¥3.80 in 1Q 2020)

New 90-day low: JP¥2,031

Analysts lower EPS estimates to JP¥20.80

Full year 2020 earnings released: EPS JP¥17.72 (vs JP¥13.84 in FY 2019)

Revenue and earnings miss expectations

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 23, 2021